SX-3228 is a selective benzodiazepine BZ1 receptor agonist used to study sleep regulation; it significantly reduces rapid-eye-movement sleep (REMS) and, when administered at the beginning of the dark period, dose-dependently decreases waking (W) and increases slow-wave sleep (SWS).